We are live on ! Find out more
SGK

Steigerwald Gordon & Koch Portfolio holdings

AUM $974M
1-Year Est. Return 13.43%
This Fund
S&P 500
This Quarter Est. Return
-12.1%
1 Year Est. Return
+13.43%
3 Year Est. Return
+53.19%
5 Year Est. Return
+76.04%
10 Year Est. Return
+263.05%
AUM
$574M
AUM Growth
-$81.1M
Cap. Flow
+$5.94M
Cap. Flow %
1.03%
Top 10 Hldgs %
31.9%
Holding
117
New
4
Increased
57
Reduced
36
Closed
8

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$8.75M
2
WBD icon
Warner Bros
WBD
+$1.12M
3
AAPL icon
Apple
AAPL
+$893K
4
DD icon
DuPont de Nemours
DD
+$583K
5
DIS icon
Walt Disney
DIS
+$530K

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$7.92M
2
T icon
AT&T
T
+$1.55M
3
DE icon
Deere & Co
DE
+$446K
4
ELV icon
Elevance Health
ELV
+$422K
5
WBA
Walgreens Boots Alliance
WBA
+$251K

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Healthcare 16.61%
3 Industrials 14.55%
4 Financials 11.39%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$28.6M 4.99%
209,498
+5,900
+3% +$893K
MSFT icon
2
Microsoft
MSFT
$2.99T
$22.2M 3.87%
86,377
+302
+0.4% +$82K
ELV icon
3
Elevance Health
ELV
$82.9B
$19.4M 3.39%
40,271
-853
-2% -$422K
ACN icon
4
Accenture
ACN
$88.6B
$17.1M 2.98%
61,565
-217
-0.4% -$65.2K
DE icon
5
Deere & Co
DE
$158B
$17M 2.97%
56,841
-1,211
-2% -$446K
JNJ icon
6
Johnson & Johnson
JNJ
$599B
$16.2M 2.82%
91,221
+454
+0.5% +$80.9K
CACI icon
7
CACI
CACI
$9.97B
$15.9M 2.77%
56,453
-619
-1% -$172K
RVTY icon
8
Revvity
RVTY
$11.9B
$15.7M 2.73%
110,240
-142
-0.1% -$21.3K
ADP icon
9
Automatic Data Processing
ADP
$102B
$15.6M 2.71%
74,151
-251
-0.3% -$55K
UPS icon
10
United Parcel Service
UPS
$96.2B
$15.3M 2.67%
84,014
+107
+0.1% +$19.5K
RTX icon
11
RTX Corp
RTX
$262B
$15.3M 2.66%
158,866
+659
+0.4% +$63.4K
TRV icon
12
Travelers Companies
TRV
$78.4B
$14.5M 2.52%
85,606
+65
+0.1% +$11.3K
V icon
13
Visa
V
$686B
$14.4M 2.5%
72,893
+201
+0.3% +$41.5K
AMGN icon
14
Amgen
AMGN
$197B
$14.3M 2.49%
58,710
+368
+0.6% +$90.2K
SYY icon
15
Sysco
SYY
$38.6B
$13.9M 2.42%
164,234
+1,065
+0.7% +$89.2K
JPM icon
16
JPMorgan Chase
JPM
$901B
$13.3M 2.32%
118,152
+2,515
+2% +$312K
GIS icon
17
General Mills
GIS
$20.1B
$12.7M 2.21%
167,784
+1,325
+0.8% +$92.8K
SYK icon
18
Stryker
SYK
$122B
$12.4M 2.15%
62,152
+927
+2% +$218K
CHKP icon
19
Check Point Software Technologies
CHKP
$14.1B
$12.2M 2.13%
100,384
+625
+0.6% +$80.2K
DKS icon
20
Dick's Sporting Goods
DKS
$19.2B
$12M 2.1%
159,728
-160
-0.1% -$14.2K
KO icon
21
Coca-Cola
KO
$353B
$12M 2.09%
190,434
+1,088
+0.6% +$69K
VTR icon
22
Ventas
VTR
$46.8B
$11.9M 2.07%
231,516
+2,206
+1% +$124K
D icon
23
Dominion Energy
D
$61.9B
$11.5M 2%
144,024
+1,507
+1% +$124K
IBM icon
24
IBM
IBM
$200B
$11M 1.91%
77,812
+1,157
+2% +$156K
WFC icon
25
Wells Fargo
WFC
$261B
$10.8M 1.88%
276,154
+4,808
+2% +$211K

Similar funds

Steigerwald Gordon & Koch's Q2 2022 Portfolio in Review

As of Q2 2022, Steigerwald Gordon & Koch held 117 positions worth $574M, down 12% from $655M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Steigerwald Gordon & Koch's Q2 2022 filing shows 4 new, 57 increased, 36 reduced and 8 closed positions. Its largest new stake was Zoetis: 50,579 shares worth $8.69M. The largest sale was Bausch Health, an estimated $7.92M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Steigerwald Gordon & Koch's largest Q2 2022 buy was Zoetis: 50,579 shares worth $8.69M.
  • Steigerwald Gordon & Koch added most to Apple in Q2 2022, an estimated $893K increase.
  • Steigerwald Gordon & Koch's biggest Q2 2022 reduction was AT&T, cutting an estimated $1.55M.
  • Steigerwald Gordon & Koch fully exited Bausch Health in Q2 2022, selling an estimated $7.92M.
  • Steigerwald Gordon & Koch's ten largest holdings make up 32% of its $574M portfolio in Q2 2022.
  • Steigerwald Gordon & Koch opened 4 new positions and closed 8 in Q2 2022.
  • Steigerwald Gordon & Koch's portfolio value fell 12% quarter-over-quarter to $574M.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2022, filed 14 Jul 2022.